The senior leadership of Arianne Consulting all have graduate degrees in biomedical scientific disciplines (MD or PhD degrees) and each have a minimum of 15 years biopharmaceutical experience. All are fluent in English and most speak additional regional languages.
Cellia Habita, MD, PhD
Chief Executive Officer
Dr. Habita is the founder of Arianne Consulting and has moved the company from a consulting group to a full service clinical CRO. She has over fifteen years experience in research and development of human therapeutics. She brings her broad scientific and clinical expertise in various therapeutic areas such as oncology, dermatology, ophthalmology, endocrinology and infectious diseases. She has advanced multiple compounds through drug development from early pre-clinical to full clinical development. Dr. Habita has completed her general residency in Paris (France), she has a master in Biology and Genetics of Aging, and a PhD in genetics of type I diabetes. She completed her graduate research at the Welcome Trust Center in Oxford (Oxford University). After completing her post-graduate training at the University of California and holding the academic position of Assistant Project Scientist in the department of Pediatrics (USCD- San Diego), she moved into local Biotech where she headed Drug Development and Clinical and Regulatory teams as Director and Senior VP, respectively.
Jennifer Ellis
Head of Regulatory Affairs
Jennifer has over 15 years of regulatory experience in pharmaceuticals, biologics and devices. She has successfully submitted new drug submissions to the North American agencies and internationally. Ms. Ellis has worked predominantly for small biotech start up companies, running regulatory departments single-handedly as well as managing teams. She has contributed on clinical development, marketing, regulatory planning and administration and traveled the world extensively, monitoring and coordinating trials internationally. Her years of working in small environments have given her the opportunity to participate in all aspects of drug development and utilize that experience in her writing, administration, development and corporate relationships.
